Navigation Links
MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext
Date:12/17/2008

's limited operating history and business development associated with being a growth stage company; its dependence on key personnel; its need to attract and retain technical and managerial personnel; its ability to execute its business strategy; the intense competition it faces; its ability to protect its intellectual property and proprietary technologies; its exposure to product liability claims resulting from the use of its products; general economic and capital market conditions; financial conditions of its customers and their perception of its financial condition relative to that of its competitors; as well as those risks described under the heading "Risk Factors" of MINRAD International's Form 10-KSB/A, filed with the Securities and Exchange Commission on April 21, 2008. Although MINRAD International, Inc. believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.

    MINRAD International, Inc.                                Contact
    50 Cobham Drive                             Charles R. Trego, Jr.
    Orchard Park, NY 14127           Executive Vice President and CFO
                                                       (716) 855-1068


'/>"/>
SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
2. MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
3. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
4. MINRAD International, Inc. Announces 2007 Financial Results
5. MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
6. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
7. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
8. MINRAD International, Inc. to Discuss Current Business Conditions on Tuesday, November 25, 2008
9. MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States
10. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
11. DaVita Receives Civil Complaint

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , , NEWPORT BEACH, Calif., Dec. 1 /PRN...lling code that insurers will reimburse them for t...n monitor for ,going under, for surgery. ,, Ane...nt brain monitoring is to avoid postop dementia fr...hesiologists have not heard the ,avoid over-medica...
(Date:12/1/2009)... , , SEATTLE, Dec. 1 /PRNewswire-F... and MTA: CTIC) management,s presentation at the 2... Tuesday, December 1 at 11:00 a.m. Eastern Time wi... ,, The presentation will take place in Holmes...available for replay after the presentation. , ,...
(Date:12/1/2009)... , CHICAGO A study presented today at the annual...ica (RSNA) revealed that MRI is a highly accurate ...ly life-threatening and increasingly common condit...ust before and after giving birth. , "Due to th...s that leave scarring on the uterine wall, coupled...
(Date:12/1/2009)... , CHICAGO Results of a randomized, controlled c...g of the Radiological Society of North America (RS...g or blockage in arteries that supply blood to the...icant but silent coronary artery disease. , Per... a combination of fat, cholesterol and other subst...
(Date:12/1/2009)... , The first ever published study of aviation-rel...re than 1,013 patients are admitted to U.S. hospit...hat 753 aviation-deaths occur each year. The study...Bloomberg School of Public Health,s Center for Inj...lso reports that the largest categories of patient...
Breaking Medicine News(10 mins):Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:MRI helps detect life-threatening pregnancy complication 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:More than 1,000 patients in US admitted annually for aviation-related injuries 2
...sorder, arterial trouble , FRIDAY, Oct. 12 (Health...sitive airway pressure (CPAP) to treat people with...y indications of atherosclerosis -- hardening of t...therosclerosis, Brazilian researchers say. , The s...
...eaction times , , SATURDAY, Oct. 13 (Healt...in medications such as morphine does not impair a ... , A team at Rush University Medical Center in Chi...out 12 minutes in a driving simulator that measure...
...vernor Schwarzenegger signed into law a package of...e and extend benefits to children and youth in,fos...important bill in this,package of legislation will...focus on developing and,strengthening life-long pe...
...Radiology Holdings, Inc. (Nasdaq: NHWK ), a leadi...ups across the United States, today announced that...ber 31, 2007 at 8:30 a.m.,(ET) with management to ... at 8:30 a.m. (ET). A live web cast of the confere...
...ealthcare Research and Quality, part of the U.S. D...today the award of $41.6 million over the next 4,y... centers as part of its,Centers for Education and ...tics,Program allows AHRQ to build a strong evidenc...
...e, Will Challenge,Corporate-Backed Proponents of "... University,professor Dale Nance, co-author of the...al Injustice, will be one of the featured speakers... Mr. Nance,s report, written with fellow professor...
Other Medicine News:Health News:Sleep Apnea Treatment Helps Stave Off Heart Disease 2Health News:Morphine Painkillers Won't Impair Driving 2Health News:California Alliance Applauds Governor's Support of Group Home Reform for Foster Youth 2Health News:California Alliance Applauds Governor's Support of Group Home Reform for Foster Youth 3Health News:NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 2Health News:AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies 2Health News:AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies 3Health News:'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel 2
(Date:12/1/2009)..., , NEW YORK, Dec. 1 /PRNewswi...ssure, changing market dynamics for an industry ex...g healthcare reforms are likely to drive up the e...e sciences industry, according to a report releas...a 2020: Taxing times ahead - Which path will you t...
(Date:11/30/2009)..., , HUNTERSVILLE, N.C., Nov. 30 /PRNewswir...der in built-in antimicrobial product protection, ...ca partnership with Dal-Tile Corp., the largest U....d natural stone. Dal-Tile Corp is launching two n...TM) featuring Microban(®) patent pending silv...
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Breast...ibutes to the detection of malignant or high-risk ... mammographic findings, according to results of a ...eting of the Radiological Society of North America...as conducted as an adjunct diagnostic imaging moda...
Breaking Medicine Technology:Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2Spherix Incorporated Announces Annual Shareholders Meeting Date 14241 1Spherix Incorporated Announces Annual Shareholders Meeting Date 14241 2Spherix Incorporated Announces Annual Shareholders Meeting Date 14241 3Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 1Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 2Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 3Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 4Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 5Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 6Predicting Postpartum Depression May Be Possible 58178 1Predicting Postpartum Depression May Be Possible 58178 2
Super Pupil XL
Superzoom 78/90
Super 66 Stereo Fundus
90D Classic
Medicine Products: